Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


Sammson gene causes melanoma

In collaboration with big N2N researchers from UGent, VIB scientists from KU Leuven have revealed a remarkable link between malignant melanoma and…


Skin on skin: Melanoma research at VIB

Melanoma is a particularly nasty type of skin cancer. It progresses and spreads very quickly, and in many cases it is resistant to chemotherapy. C…

POPULAR TAGS

GlycoCirrho test predicts liver cancer

Written by LVS on in the category news with the tags , , .


Researchers at the UZ Ghent have discovered that the GlycoCirrhoTest for the early detection of cirrhosis also accurately predicts the risk for the development of liver cancer. Their results are presented this week at United European Gastroenterology, the most important conference in the field. 

Cirrhosis is a severe and chronic inflammation of the liver and is mostly caused by alcohol abuse or infection with the Hepatitis B or C virus. Cirrhosis is also an important risk factor for the development of hepatocellular carcinoma (HCC), the most common type of liver cancer. One in three cirrhosis patients eventually develop HCC.

In 2004, the research groups of Nico Callewaert and Hans Van Vlierberghe from the VIB and UZ Ghent developed a test for the early detection of cirrhosis. The so-called GlycoCirrhoTest does this by analyzing the glycosylation of blood serum proteins. The researchers now discovered that the test is also predictive for HCC. The GlycoCirrhoTest was used in 132 cirrhosis patients who were monitored for four years. Patients who developed HCC within these four years showed significantly higher values for the test. In this way, patients can be divided in high and low risk groups for HCC and personalized follow-up can be implemented. Early detection of liver cancer drastically improves prognosis of patients.

Read more about: , , .

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


Sammson gene causes melanoma

In collaboration with big N2N researchers from UGent, VIB scientists from KU Leuven have revealed a remarkable link between malignant melanoma and…


Skin on skin: Melanoma research at VIB

Melanoma is a particularly nasty type of skin cancer. It progresses and spreads very quickly, and in many cases it is resistant to chemotherapy. C…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

V-Bio Ventures Flanders.bio XpandInnovation UGent Biowin Itera Life Science Turnstone KU Leuven Janssen GSK

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.